Update shared on 06 Nov 2025
Fair value Decreased 0.44%Capcom's analyst price target was modestly reduced from ¥4,641.25 to ¥4,620.63 as analysts cite slightly slower projected revenue growth, with this being offset in part by improved profit margin expectations.
What's in the News
- Capcom announces dividend increase to JPY 20.00 per share for the fiscal second quarter ending March 31, 2026, scheduled for payment starting November 17, 2025 (Key Developments).
- Beard Papa's collaborates with Capcom for a Monster Hunter Wilds co-promotion from October 10 to 31, 2025, offering themed desserts, exclusive in-game rewards, and limited edition merchandise at select U.S. locations (Key Developments).
- Resident Evil Requiem, along with Resident Evil 7 biohazard and Resident Evil Village, will launch for Nintendo Switch 2 on February 27, 2026, as Capcom expands its multi-platform portfolio. Resident Evil Requiem has already won four Gamescom Awards 2025 (Key Developments).
- "Assassin's Creed Shadows" surpasses Capcom's Monster Hunter Wilds in 2025 European new game sales, as per TGB data (Periodicals).
Valuation Changes
- Consensus Analyst Price Target decreased modestly from ¥4,641.25 to ¥4,620.63.
- Discount Rate increased slightly from 7.01% to 7.09%.
- Revenue Growth projection fell from 6.58% to 5.21%.
- Net Profit Margin expectation improved from 31.75% to 32.14%.
- Future P/E ratio declined from 33.34x to 32.60x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.